Render Target: STATIC
Render Timestamp: 2024-11-19T10:51:07.750Z
Commit: 5c4accf06eb7154018ba3f54329c7590f97f534a
XML generation date: 2024-09-20 06:23:27.902
Product last modified at: 2024-08-23T13:30:07.637Z
1% for the planet logo
PDP - Template Name: Chemical Modulators
PDP - Template ID: *******c501c72

Puromycin Dihydrochloride #40939

    Product Information

    Product Usage Information

    Puromycin Dihydrochloride is supplied as a lyophilized powder. For a 10 mM stock, reconstitute 5 mg of powder in 0.92 mL of DMSO. Working concentrations and length of treatment can vary depending on the desired effect.

    Storage

    Store lyophilized at -20ºC, desiccated. In lyophilized form, the chemical is stable for 24 months. Once in solution, store at -20ºC and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

    Product Description

    Molecular Weight 544.4 g/mol
    Purity >98%
    Molecular Formula C22H29N7O5 • 2HCl
    CAS 58-58-2
    Solubility Soluble in DMSO at 50 mg/mL or water at 50 mg/mL.

    Background

    Puromycin Dihydrochloride is hydrochloride salt that is part of the antibiotic puromycin, originally isolated from the bacterium Streptomyces alboniger. The clinical use of puromycin as an antibiotic has been limited as it is non-selective and highly toxic. Instead, puromycin has been used to study mechanisms of protein synthesis as it associates with growing polypeptide chains and causes premature chain termination (1). The structure of puromycin is analogous to the 3’ end of aminoacyl-tRNA, which allows puromycin to compete with aminoacyl-tRNA for binding at the A’ site of the peptidyl transferase center during protein translation. Puromycin binding results in premature chain release from the ribosome and a truncated, puromycylated polypeptide (2). As these puromycylated nascent polypeptide chains can be detected using anti-puromycin antibodies, incorporation of puromycin into newly synthesized proteins has been used to estimate the rate and localization of protein synthesis (3). The use of puromycin labeling to estimate protein synthesis may be limited by cell conditions (e.g., energy starvation); similar limits are seen in studies using puromycin to localize areas of protein synthesis (4,5).
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.